![Frederic Vigneault](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Frederic Vigneault
Società | Posizione | Inizio | Fine |
---|---|---|---|
Unravel Biosciences, Inc.
![]() Unravel Biosciences, Inc. BiotechnologyHealth Technology Unravel Biosciences is a rapid prototyping therapeutics company that uses AI biological network analysis and existing drugs to discover and clinically derisk entirely novel therapeutics and biomarkers for complex diseases. Unravel Biosciences is based in Boston, MA and was founded by Richard Novak, Frederic Vigneault, Michael Levin, and Donald Ingber. The company leverages its proprietary Bionav™ platform to combine target and drug discovery, preclinical screening, and patient stratification. Richard Novak has been the CEO since incorporation. | Direttore/Membro del Consiglio | - | - |
Direttore Tecnico/Scientifico/R&S | - | - | |
Fondatore | - | - |
Storia della carriera di Frederic Vigneault
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Unravel Biosciences, Inc.
![]() Unravel Biosciences, Inc. BiotechnologyHealth Technology Unravel Biosciences is a rapid prototyping therapeutics company that uses AI biological network analysis and existing drugs to discover and clinically derisk entirely novel therapeutics and biomarkers for complex diseases. Unravel Biosciences is based in Boston, MA and was founded by Richard Novak, Frederic Vigneault, Michael Levin, and Donald Ingber. The company leverages its proprietary Bionav™ platform to combine target and drug discovery, preclinical screening, and patient stratification. Richard Novak has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Frederic Vigneault
- Esperienza